Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
Organogenesis Holdings (Nasdaq: ORGO), a regenerative medicine company specializing in Advanced Wound Care and Surgical & Sports Medicine markets, has announced its participation in two major healthcare investor conferences in September.
Management will present at the Cantor Fitzgerald Global Healthcare Conference on September 3 at 2:10 p.m. ET and the Morgan Stanley Global Healthcare Conference on September 10 at 2:35 p.m. ET. Both events will take place in New York City and feature fireside chat sessions that will be available via webcast on the company's investor relations website for approximately 30 days after the events.
Organogenesis Holdings (Nasdaq: ORGO), azienda di medicina rigenerativa specializzata nei settori Advanced Wound Care e Surgical & Sports Medicine, ha comunicato la propria partecipazione a due importanti conferenze per investitori nel settore sanitario a settembre.
La direzione terrà una presentazione al Cantor Fitzgerald Global Healthcare Conference il 3 settembre alle 14:10 ET e al Morgan Stanley Global Healthcare Conference il 10 settembre alle 14:35 ET. Entrambi gli eventi si svolgeranno a New York City e prevedono sessioni in formato fireside chat che saranno disponibili in webcast sul sito investor relations della società per circa 30 giorni dopo gli eventi.
Organogenesis Holdings (Nasdaq: ORGO), compañía de medicina regenerativa especializada en Advanced Wound Care y Surgical & Sports Medicine, ha anunciado su participación en dos importantes conferencias para inversores del sector sanitario en septiembre.
La dirección presentará en la Cantor Fitzgerald Global Healthcare Conference el 3 de septiembre a las 2:10 p.m. ET y en la Morgan Stanley Global Healthcare Conference el 10 de septiembre a las 2:35 p.m. ET. Ambos eventos se celebrarán en la ciudad de Nueva York y contarán con charlas tipo fireside chat que estarán disponibles en webcast en la web de relaciones con inversores de la compañía durante aproximadamente 30 días después de los eventos.
Organogenesis Holdings (Nasdaq: ORGO), Advanced Wound Care 및 Surgical & Sports Medicine 분야를 전문으로 하는 재생의학 기업은 9월에 열리는 주요 의료 투자자 컨퍼런스 두 곳에 참여한다고 발표했습니다.
경영진은 Cantor Fitzgerald Global Healthcare Conference에서 9월 3일 오후 2시 10분(동부시간)에, Morgan Stanley Global Healthcare Conference에서 9월 10일 오후 2시 35분(동부시간)에 발표를 진행합니다. 두 행사는 모두 뉴욕시에서 개최되며, fireside chat 형식의 세션은 회사 투자자관계 웹사이트를 통해 행사 종료 후 약 30일간 웹캐스트로 시청하실 수 있습니다.
Organogenesis Holdings (Nasdaq: ORGO), entreprise de médecine régénérative spécialisée dans les segments Advanced Wound Care et Surgical & Sports Medicine, a annoncé sa participation à deux grandes conférences pour investisseurs du secteur de la santé en septembre.
La direction interviendra lors du Cantor Fitzgerald Global Healthcare Conference le 3 septembre à 14h10 ET et du Morgan Stanley Global Healthcare Conference le 10 septembre à 14h35 ET. Les deux événements se tiendront à New York et comprendront des sessions de type « fireside chat » disponibles en webcast sur le site des relations investisseurs de la société pendant environ 30 jours après les conférences.
Organogenesis Holdings (Nasdaq: ORGO), ein Unternehmen der regenerativen Medizin mit Schwerpunkt auf Advanced Wound Care sowie Surgical & Sports Medicine, hat seine Teilnahme an zwei großen Healthcare-Investorenkonferenzen im September angekündigt.
Das Management wird am Cantor Fitzgerald Global Healthcare Conference am 3. September um 14:10 Uhr ET und am Morgan Stanley Global Healthcare Conference am 10. September um 14:35 Uhr ET präsentieren. Beide Veranstaltungen finden in New York City statt und umfassen Fireside-Chat-Sitzungen, die etwa 30 Tage nach den Events per Webcast auf der Investor-Relations-Website des Unternehmens verfügbar sein werden.
- None.
- None.
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences:
The Cantor Fitzgerald Global Healthcare Conference at the New York Marriott Marquis in New York, NY
- Management will participate in a fireside chat on Wednesday, September 3 at 2:10 p.m. Eastern Time.
The Morgan Stanley Global Healthcare Conference at the Sheraton Times Square in New York, NY
- Management will participate in a fireside chat on Wednesday, September 10 at 2:35 p.m. Eastern Time
Webcasts of the fireside chat sessions will be accessible by visiting the “News & Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. Archives of the webcasts will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com
Investor Inquiries: ICR Healthcare Mike Piccinino, CFA OrganoIR@ICRHealthcare.com Press and Media Inquiries: Organogenesis communications@organo.com
FAQ
When is Organogenesis (ORGO) presenting at the Cantor Fitzgerald Healthcare Conference 2025?
When is Organogenesis (ORGO) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Organogenesis (ORGO) conference presentations?
What markets does Organogenesis (ORGO) operate in?
